Business
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
Coloplast announces changes to Executive Leadership Team The Coloplast Board of Directors are making changes to the Executive Leadership Team (ELT) to support the successful execution of the new Coloplast Group strategy. Over the last couple of months, senior leaders from across the Coloplast Group have worked together to finalise the new Coloplast Group strategy, which will be communicated internally and externally in early September following approval by the Board of Directors. “Our new strate
About this update from Coloplast A/s Class B
[{"type":"image","alt":"Coloplast A/S","displaySize":"","headline":null,"caption":"Coloplast A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":144,"url":"https://media.zenfs.com/en/globenewswire.com/e8ee650caffe7b5e9474eaac1733b4ef"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CnHAOjRIde9xT5OfHxnjSg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e8ee650caffe7b5e9474eaac1733b4ef","width":300,"height":144}},"lazy":false},{"type":"text","content":"Coloplast announces changes to Executive Leadership Team","length":56,"tagName":"p"},{"type":"text","content":"The Coloplast Board of Directors are making changes to the Executive Leadership Team (ELT) to support the successful execution of the new Coloplast Group strategy.","length":163,"tagName":"p"},{"type":"text","content":"Over the last couple of months, senior leaders from across the Coloplast Group have worked together to finalise the new Coloplast Group strategy, which will be communicated internally and externally in early September following approval by the Board of Directors.","length":263,"tagName":"p"},{"type":"text","content":"“Our new strategy is centered around our customers. We will create and deliver the best customer experience for our users, patients and clinicians across our offering of products, support and services. Our ambition is to set the standard of care, to lead the market and to win!” says Lars Rasmussen, interim CEO of Coloplast.","length":325,"tagName":"p"},{"type":"text","content":"“To deliver value for our customers, shareholders and more, we must evolve. That means putting the customer at the centre of everything we do. It also means delivering a step change in innovation to solidify our position as the innovation leader in our industry,” says Lars.","length":274,"tagName":"p"},{"type":"text","content":"During the current strategy period, the Coloplast Group has expanded with the addition of Atos Medical and Kerecis. Effective immediately, the company will organise its businesses into two distinct business units: Chronic Care and Acute Care. This structure allows the company to respect the differences in market dynamics, customer needs, patient pathways and business models, and it creates the needed structure to execute on the company’s 2030 strategy.","length":456,"tagName":"p"},{"type...